DecisionView Launches StudyOptimizer 4
San Francisco, CA – December 10, 2009
DecisionView Inc., a provider of software solutions to optimize clinical trial enrollment for life sciences companies, today announced the release of StudyOptimizer™ 4, the latest iteration of its Web-based solution. DecisionView’s flagship product now includes advanced historical analysis and templates capabilities, as well as enhancements to its predictive analytics technology.
StudyOptimizer allows clinical trial managers to plan, track, diagnose, and correct enrollment plans via a single centralized Web-based application that
captures clinical trial patient enrollment data from across the organization. The application uses predictive analytics to forecast enrollment trends and estimate completion dates, which are updated based on actual enrollment patterns giving clinical trial managers information to measure actual and projected performance against plan.
“The ability to capture, analyze, and leverage historical clinical trial enrollment data in planning future patient recruitment efforts provides a critical baseline that life sciences organizations need in order to benchmark and improve these processes,” said said Alan Louie, Ph.D., Research Director, IDC.
Recently, DecisionView announced the availability of the Software-as-a-Service (SaaS) version of
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025